Anvesana

Anvesana Develops Therapies for Hereditary Blood and Bleeding Disorders, Aiming to Treat Rare Genetic Diseases Caused by Insufficient Protein Production. The Company Specializes in RNA Sequence Analysis and the Identification of Targetable Gene Expression Upregulation Regions, Enabling Patients to Cure Rare Genetic Diseases Caused by Gene Dosage Effects, for Which There Are Currently No Approved Disease-Modifying Therapies.